Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients

被引：0
|
作者：
Alain Mina
Hind Rafei
Maya Khalil
Yasmine Hassoun
Zeina Nasser
Arafat Tfayli
机构：
[1] American University of Beirut,Department of Internal Medicine
[2] Internal Medicine Resident-University of Miami Miller School of Medicine-Palm Beach Regional Campus,Department of Internal Medicine
[3] American University of Beirut Medical Center,Faculty of Public Health
[4] Free University of Brussels,undefined
来源：
BMC Cancer | / 15卷
关键词：
Breast cancer; Echocardiography; Anthracycline;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] ANTHRACYCLINE-BASED CHEMOTHERAPY FOR BREAST CANCER - PREDICTIVE FACTORS OF DOSE INTENSITY REDUCTION
    Faustino, C.
    Afonso, N.
    Sousa, B.
    Rodrigues, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 82 - 82
  • [42] More than half of breast cancer patients develop diastolic dysfunction after anthracycline-based chemotherapy
    Serrano, Jose M.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2015, 76 (08) : 443 - 443
  • [43] Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy
    Vargas-Roig, L. M.
    Cuello-Carrion, F. D.
    Fernandez-Escobar, N.
    Daguerre, P.
    Leuzzi, M.
    Ibarra, J.
    Gago, F. E.
    Nadin, S. B.
    Ciocca, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Menstrual disorders during anthracycline-based adjuvant chemotherapy in very young early breast cancer patients
    Neskovic-Konstantinovic, Z.
    Strbac, D.
    Susnjar, S.
    Vukotic, D.
    Gavrilovic, D.
    BREAST, 2007, 16 : S42 - S42
  • [45] Benefits of dexrazoxane in female patients with stage II breast cancer treated with anthracycline-based adjuvant chemotherapy
    Schnirer, I. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] The incidence of symptomatic thromboembolism in patients receiving adjuvant anthracycline-based chemotherapy for early stage breast cancer
    Nolan, Luke
    Darby, Angela
    Boleti, Katia
    Simmonds, Peter
    BREAST, 2011, 20 (02): : 151 - 154
  • [47] Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors
    Serrano, Jose M.
    Mata, Rebeca
    Gonzalez, Iria
    Del Castillo, Silvia
    Muniz, Javier
    Morales, Luis J.
    Espinosa, Maria Jesus
    Moreno, Fernando
    Jimenez, Rosa
    Cristobal, Carmen
    Graupner, Catherine
    Talavera, Pedro
    Landaluce, Carlos Gutierez
    Curcio, Alejandro
    Alonso, Javier
    Guerra, Juan A.
    Alonso, Joaquin J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 382 : 52 - 59
  • [48] Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer
    Chavez-MacGregor, Mariana
    Brown, Erika
    Lei, Xiudong
    Litton, Jennifer
    Meric-Bernstram, Funda
    Mettendorf, Elizabeth
    Hernandez, Leonel
    Valero, Vicente
    Hortobagyi, Gabriel N.
    Gonzalez-Angulo, Ana Maria
    CANCER, 2012, 118 (02) : 326 - 332
  • [49] Cisplatin and paclitaxel for treatment of patients with advanced or metastatic breast cancer, previously treated with anthracycline-based chemotherapy
    Munarriz, A
    Oltra, A
    Santaballa, A
    Segura, A
    Pastor, M
    Montalar, J
    Herranz, C
    10TH INTERNATIONAL CONGRESS ON SENOLOGY - BREAST DISEASES OF THE SENOLOGIC INTERNATIONAL SOCIETY, 1998, : 765 - 768
  • [50] HMGA2 expression and response to anthracycline-based preoperative chemotherapy in patients with operable breast cancer
    Puglisi, F.
    Ermacora, P.
    Driol, P.
    Masolini, P.
    Alessi, B.
    Pisa, F. E.
    Pandolfi, M.
    Mansutti, M.
    Giancotti, V.
    Di Loreto, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345